Zobrazeno 1 - 10
of 91
pro vyhledávání: '"M. Simó Perdigó"'
Akademický článek
Tento výsledek nelze pro nepřihlášené uživatele zobrazit.
K zobrazení výsledku je třeba se přihlásit.
K zobrazení výsledku je třeba se přihlásit.
Autor:
Olimpia Orozco-Gálvez, M. Simó-Perdigó, Iago Pinal-Fernandez, Fernando Martínez-Valle, Andreu Fernández-Codina
Publikováno v:
Clinical Nuclear Medicine. 46:e307-e311
Objective The aim of this study was to assess disease activity by different PET/CT measurements in IgG4-related disease (IgG4-RD) flares and their correlation with the IgG4-RD responder index (IgG4-RI). Patients and methods Patients were retrospectiv
Publikováno v:
Revista Española de Medicina Nuclear e Imagen Molecular (English Edition). 40:123-135
The treatment of cancer by immunotherapy has been a revolution, as it is the first strategy that manages to control the disease for prolonged periods of time. Its efficacy is associated with different imaging response patterns and the appearance of n
Publikováno v:
Revista Española de Medicina Nuclear e Imagen Molecular. 40:123-135
Resumen El tratamiento del cancer mediante inmunoterapia ha supuesto una revolucion, ya que es la primera estrategia que consigue controlar la enfermedad por periodos prolongados de tiempo. Su eficacia va asociada a diferentes patrones de respuesta p
Autor:
M. Simó-Perdigó, F. Martinez-Valle
Publikováno v:
Revista Española de Medicina Nuclear e Imagen Molecular. 40:107-114
Resumen La enfermedad relacionada con IgG4 (ER-IgG4) es una enfermedad sistemica reconocida. Se describio tras observarse que pacientes diagnosticados de pancreatitis autoinmune mostraban signos de enfermedad extrapancreatica. La clinica de estos pac
Autor:
F. Martinez-Valle, M. Simó-Perdigó
Publikováno v:
Revista Española de Medicina Nuclear e Imagen Molecular (English Edition). 40:107-114
IgG4-related disease (ER-IgG4) is a recognised systemic disease. It was described after patients diagnosed with autoimmune pancreatitis showed signs of extra-pancreatic disease. The clinical manifestation of these patients is subacute and is manifest
Publikováno v:
Revista Española de Medicina Nuclear e Imagen Molecular. 39:233-243
Soft tissue sarcomas (STS) are a rare and heterogeneous group of tumors. They account for 1% of solid malignant tumors in adults and 7% in children and are responsible for 2% of cancer mortality. They require a multidisciplinary approach in centers w
Publikováno v:
Revista Española de Medicina Nuclear e Imagen Molecular (English Edition). 39:233-243
Soft tissue sarcomas (STS) are a rare and heterogeneous group of tumors. They account for 1% of solid malignant tumors in adults and 7% in children and are responsible for 2% of cancer mortality. They require a multidisciplinary approach in centers w
Publikováno v:
Revista espanola de medicina nuclear e imagen molecular. 40(5)
Autor:
Ernesto Trallero-Araguás, Albert Gil-Vila, X. Martínez-Gómez, Iago Pinal-Fernández, M. Alvarado-Cardenas, M. Simó-Perdigó, Albert Selva-O'Callaghan
Publikováno v:
Seminars in arthritis and rheumatism. 53
There is a well-recognized association between cancer and myositis, so cancer screening at diagnosis is recommended. We aim to report the results of our cancer screening strategy and to ascertain the reliability of using PET/CT to identify cancer-ass